SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Gamida Cell Ltd. (GMDA) , forward earnings yield 2,500.00%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 0.0
Overall SharesGrow Score: 28/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GMDA
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio2.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.57
Forward EPS (Est.)$0.90
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield2,500.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.26 |
$0.00 |
$-22.67M |
- |
| 2017 |
$-1.06 |
$0.00 |
$-19.01M |
- |
| 2018 |
$-10.53 |
$0.00 |
$-52.93M |
- |
| 2019 |
$-1.16 |
$0.00 |
$-34.35M |
- |
| 2020 |
$-1.75 |
$0.00 |
$-76.45M |
- |
| 2021 |
$-1.56 |
$0.00 |
$-92.42M |
- |
| 2022 |
$-2.42 |
$0.00 |
$-154.37M |
- |
| 2023 |
$-0.57 |
$1.78M |
$-63M |
-3531.2% |
